TOTUOP
DNA icon

Trustees of The University of Pennsylvania’s Ginkgo Bioworks DNA Stock Holding History

Trustees of The University of Pennsylvania’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,918
Closed -$1.6M – 6
2022
Q1 		$1.6M Buy
+9,918
New +$1.93M 1.21% 6

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Trustees of The University of Pennsylvania's DNA Position: Q2 2022 in Review

Trustees of The University of Pennsylvania sold out of Ginkgo Bioworks (DNA) in Q2 2022, closing a stake of 9,918 shares — an estimated $1.6M sold.

Trustees of The University of Pennsylvania first reported a position in DNA in Q1 2022 and held it in 1 quarter. The position peaked at $1.6M in Q1 2022. 260 funds tracked by Wall St. Rank hold DNA as of Q2 2022.

  • Trustees of The University of Pennsylvania reported no remaining Ginkgo Bioworks position as of Q2 2022 after selling out during the quarter.
  • Trustees of The University of Pennsylvania sold 9,918 Ginkgo Bioworks shares in Q2 2022, an estimated $1.6M.
  • Trustees of The University of Pennsylvania first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 1 quarter.
  • Trustees of The University of Pennsylvania's Ginkgo Bioworks position peaked at $1.6M in Q1 2022.
  • 260 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2022.

Based on Trustees of The University of Pennsylvania's 13F filing for Q2 2022, filed 12 Aug 2022.